1 Introduction to Research & Analysis Reports
1.1 Needle-Free Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Needle-Free Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Needle-Free Influenza Vaccine Overall Market Size
2.1 Global Needle-Free Influenza Vaccine Market Size: 2022 VS 2029
2.2 Global Needle-Free Influenza Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Needle-Free Influenza Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Needle-Free Influenza Vaccine Players in Global Market
3.2 Top Global Needle-Free Influenza Vaccine Companies Ranked by Revenue
3.3 Global Needle-Free Influenza Vaccine Revenue by Companies
3.4 Global Needle-Free Influenza Vaccine Sales by Companies
3.5 Global Needle-Free Influenza Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Needle-Free Influenza Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Needle-Free Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Needle-Free Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Needle-Free Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Needle-Free Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Needle-Free Influenza Vaccine Market Size Markets, 2022 & 2029
4.1.2 Live Attenuated Influenza Vaccine
4.1.3 Split Influenza Vaccine
4.2 By Type – Global Needle-Free Influenza Vaccine Revenue & Forecasts
4.2.1 By Type – Global Needle-Free Influenza Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Needle-Free Influenza Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Needle-Free Influenza Vaccine Sales & Forecasts
4.3.1 By Type – Global Needle-Free Influenza Vaccine Sales, 2018-2023
4.3.2 By Type – Global Needle-Free Influenza Vaccine Sales, 2024-2029
4.3.3 By Type – Global Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Needle-Free Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Needle-Free Influenza Vaccine Market Size, 2022 & 2029
5.1.2 3-17 Years
5.1.3 Others
5.2 By Application – Global Needle-Free Influenza Vaccine Revenue & Forecasts
5.2.1 By Application – Global Needle-Free Influenza Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Needle-Free Influenza Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Needle-Free Influenza Vaccine Sales & Forecasts
5.3.1 By Application – Global Needle-Free Influenza Vaccine Sales, 2018-2023
5.3.2 By Application – Global Needle-Free Influenza Vaccine Sales, 2024-2029
5.3.3 By Application – Global Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Needle-Free Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Needle-Free Influenza Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Needle-Free Influenza Vaccine Revenue & Forecasts
6.2.1 By Region – Global Needle-Free Influenza Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Needle-Free Influenza Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Needle-Free Influenza Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Needle-Free Influenza Vaccine Sales & Forecasts
6.3.1 By Region – Global Needle-Free Influenza Vaccine Sales, 2018-2023
6.3.2 By Region – Global Needle-Free Influenza Vaccine Sales, 2024-2029
6.3.3 By Region – Global Needle-Free Influenza Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Needle-Free Influenza Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Needle-Free Influenza Vaccine Sales, 2018-2029
6.4.3 US Needle-Free Influenza Vaccine Market Size, 2018-2029
6.4.4 Canada Needle-Free Influenza Vaccine Market Size, 2018-2029
6.4.5 Mexico Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Needle-Free Influenza Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Needle-Free Influenza Vaccine Sales, 2018-2029
6.5.3 Germany Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.4 France Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.5 U.K. Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.6 Italy Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.7 Russia Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Needle-Free Influenza Vaccine Market Size, 2018-2029
6.5.9 Benelux Needle-Free Influenza Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Needle-Free Influenza Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Needle-Free Influenza Vaccine Sales, 2018-2029
6.6.3 China Needle-Free Influenza Vaccine Market Size, 2018-2029
6.6.4 Japan Needle-Free Influenza Vaccine Market Size, 2018-2029
6.6.5 South Korea Needle-Free Influenza Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Needle-Free Influenza Vaccine Market Size, 2018-2029
6.6.7 India Needle-Free Influenza Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Needle-Free Influenza Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Needle-Free Influenza Vaccine Sales, 2018-2029
6.7.3 Brazil Needle-Free Influenza Vaccine Market Size, 2018-2029
6.7.4 Argentina Needle-Free Influenza Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Needle-Free Influenza Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Needle-Free Influenza Vaccine Sales, 2018-2029
6.8.3 Turkey Needle-Free Influenza Vaccine Market Size, 2018-2029
6.8.4 Israel Needle-Free Influenza Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Needle-Free Influenza Vaccine Market Size, 2018-2029
6.8.6 UAE Needle-Free Influenza Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Needle-Free Influenza Vaccine Major Product Offerings
7.1.4 AstraZeneca Needle-Free Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Cipla
7.2.1 Cipla Company Summary
7.2.2 Cipla Business Overview
7.2.3 Cipla Needle-Free Influenza Vaccine Major Product Offerings
7.2.4 Cipla Needle-Free Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Cipla Key News & Latest Developments
7.3 BCHT
7.3.1 BCHT Company Summary
7.3.2 BCHT Business Overview
7.3.3 BCHT Needle-Free Influenza Vaccine Major Product Offerings
7.3.4 BCHT Needle-Free Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 BCHT Key News & Latest Developments
8 Global Needle-Free Influenza Vaccine Production Capacity, Analysis
8.1 Global Needle-Free Influenza Vaccine Production Capacity, 2018-2029
8.2 Needle-Free Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Needle-Free Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Needle-Free Influenza Vaccine Supply Chain Analysis
10.1 Needle-Free Influenza Vaccine Industry Value Chain
10.2 Needle-Free Influenza Vaccine Upstream Market
10.3 Needle-Free Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Needle-Free Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の無針インフルエンザワクチン市場予測2023-2029：弱毒化生インフルエンザワクチン、スプリットインフルエンザワクチン |
| 【英語タイトル】Needle-Free Influenza Vaccine Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5350 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：78 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医療機器＆消耗品 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の無針インフルエンザワクチン市場規模と予測を収録しています。・世界の無針インフルエンザワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界の無針インフルエンザワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の無針インフルエンザワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「弱毒化生インフルエンザワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 無針インフルエンザワクチンのグローバル主要企業は、AstraZeneca、 Cipla、 BCHTなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、無針インフルエンザワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の無針インフルエンザワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界の無針インフルエンザワクチン市場：タイプ別市場シェア、2022年 ・弱毒化生インフルエンザワクチン、スプリットインフルエンザワクチン 世界の無針インフルエンザワクチン市場：用途別、2018年-2023年、2024年-2029年 世界の無針インフルエンザワクチン市場：用途別市場シェア、2022年 ・3-17歳、その他 世界の無針インフルエンザワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界の無針インフルエンザワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における無針インフルエンザワクチンのグローバル売上、2018年-2023年 ・主要企業における無針インフルエンザワクチンのグローバル売上シェア、2022年 ・主要企業における無針インフルエンザワクチンのグローバル販売量、2018年-2023年 ・主要企業における無針インフルエンザワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 AstraZeneca、 Cipla、 BCHT ************************************************************* ・調査・分析レポートの概要 無針インフルエンザワクチン市場の定義 市場セグメント 世界の無針インフルエンザワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の無針インフルエンザワクチン市場規模 世界の無針インフルエンザワクチン市場規模：2022年 VS 2029年 世界の無針インフルエンザワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの無針インフルエンザワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の無針インフルエンザワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：弱毒化生インフルエンザワクチン、スプリットインフルエンザワクチン 無針インフルエンザワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：3-17歳、その他 無針インフルエンザワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別無針インフルエンザワクチン市場規模 2022年と2029年 地域別無針インフルエンザワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） AstraZeneca、 Cipla、 BCHT ... |
This report aims to provide a comprehensive presentation of the global market for Needle-Free Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-Free Influenza Vaccine. This report contains market size and forecasts of Needle-Free Influenza Vaccine in global, including the following market information:
Global Needle-Free Influenza Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Needle-Free Influenza Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Needle-Free Influenza Vaccine companies in 2022 (%)
The global Needle-Free Influenza Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Live Attenuated Influenza Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Needle-Free Influenza Vaccine include AstraZeneca, Cipla and BCHT, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Needle-Free Influenza Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Needle-Free Influenza Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Needle-Free Influenza Vaccine Market Segment Percentages, by Type, 2022 (%)
Live Attenuated Influenza Vaccine
Split Influenza Vaccine
Global Needle-Free Influenza Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Needle-Free Influenza Vaccine Market Segment Percentages, by Application, 2022 (%)
3-17 Years
Others
Global Needle-Free Influenza Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Needle-Free Influenza Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Needle-Free Influenza Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Needle-Free Influenza Vaccine revenues share in global market, 2022 (%)
Key companies Needle-Free Influenza Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Needle-Free Influenza Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Cipla
BCHT
Outline of Major Chapters:
Chapter 1: Introduces the definition of Needle-Free Influenza Vaccine, market overview.
Chapter 2: Global Needle-Free Influenza Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Needle-Free Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Needle-Free Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Needle-Free Influenza Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の無針インフルエンザワクチン市場予測2023-2029：弱毒化生インフルエンザワクチン、スプリットインフルエンザワクチン] (コード：MMG23JU5350)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の無針インフルエンザワクチン市場予測2023-2029：弱毒化生インフルエンザワクチン、スプリットインフルエンザワクチン]についてメールでお問い合わせ |
